Biochemical characterization of atherosclerotic plaques by endogenous multispectral fluorescence lifetime imaging microscopy
Abstract Objective To investigate the potential of endogenous multispectral fluorescence lifetime imaging microscopy (FLIM) for biochemical characterization of human coronary atherosclerotic plaques. Methods Endogenous multispectral FLIM imaging was performed on the lumen of 58 segments of postmorte...
Gespeichert in:
Veröffentlicht in: | Atherosclerosis 2012-02, Vol.220 (2), p.394-401 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract Objective To investigate the potential of endogenous multispectral fluorescence lifetime imaging microscopy (FLIM) for biochemical characterization of human coronary atherosclerotic plaques. Methods Endogenous multispectral FLIM imaging was performed on the lumen of 58 segments of postmortem human coronary artery. The fluorescence was separated into three emission bands targeting the three main arterial endogenous fluorophores (390 ± 20 nm for collagen, 452 ± 22.5 nm for elastin, and 550 ± 20 for lipids). The fluorescence normalized intensity and average lifetime from each emission band was used to classify each pixel of an image as either “High-Collagen”, “High-Lipids” or “Low-Collagen/Lipids” via multiclass Fisher's linear discriminant analysis. Results Classification of plaques as either “High-Collagen”, “High-Lipids” or “Low-Collagen/Lipids” based on the endogenous multispectral FLIM was achieved with a sensitivity/specificity of 96/98%, 89/99%, and 99/99%, respectively, where histopathology served as the gold standard. Conclusion The endogenous multispectral FLIM approach we have taken, which can readily be adapted for in vivo intravascular catheter based imaging, is capable of reliably identifying plaques with high content of either collagen or lipids. |
---|---|
ISSN: | 0021-9150 1879-1484 |
DOI: | 10.1016/j.atherosclerosis.2011.10.034 |